| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $407.3M | +22.1% |
| Cost of Revenue | $39.5M | -21.8% |
| R&D Expense | $71.5M | +36.7% |
| SG&A Expense | $337.2M | +30.4% |
| Operating Income | -$41.0M | -46.6% |
| Pre-tax Income | -$60.6M | -56.0% |
| Income Tax | $969K | +264.3% |
| Net Income | -$61.6M | -57.4% |
| EPS (Basic) | -$0.26 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.0M | +4.7% |
| Accounts Receivable | $71.8M | +24.5% |
| Inventory | $123.1M | +35.0% |
| Current Assets | $382.3M | +7.3% |
| Total Assets | $501.6M | +15.1% |
| Current Liabilities | $88.6M | +13.8% |
| Long-term Debt | $202.8M | +34.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.5M | +5.2% |
| Capital Expenditures | $1.5M | +47.6% |
| Investing Cash Flow | -$9.0M | +51.1% |
| Financing Cash Flow | $54.5M | -48.9% |
| Free Cash Flow | -$44.0M | +4.0% |
| -52.9% |
| EPS (Diluted) | -$0.26 | -52.9% |
| Total Liabilities |
| $334.7M |
| +27.5% |
| Stockholders' Equity | $166.9M | -3.7% |